Estimation of salivary and serum basic fibroblast growth factor in treated and untreated patients with oral squamous cell carcinoma

This study demonstrates the reliability of salivary bFGF marker as diagnostic as well as prognostic marker. Serum bFGF could also be used as prognostic marker only in Oral Squamous cell carcinoma patients.